Related Experiment Video
Updated: May 14, 2026

06:54
A Model for Encephalomyosynangiosis Treatment after Middle Cerebral Artery Occlusion-Induced Stroke in Mice
Published on: June 22, 2022
Temporal Muscle Thickness Is a Prognostic Factor for Neurological Recovery After Surgery for Chronic Subdural
Nikolina Šilješ1, Zara Miočić2, Irina Bagić3,4
1Department of Radiology, University Hospital Osijek, 31000 Osijek, Croatia.
Diagnostics (Basel, Switzerland)
|May 13, 2026
Summary
Temporal muscle thickness measured on CT scans predicts better neurological recovery in patients undergoing surgery for chronic subdural hematoma (CSDH). This non-invasive marker aids in risk stratification for improved patient outcomes.
Area of Science:
- Neurosurgery
- Radiology
- Geriatrics
- Sarcopenia Research
Background:
- Sarcopenia is an emerging prognostic factor in surgical patients.
- Chronic subdural hematoma (CSDH) surgery outcomes require better predictive markers.
- Cranial CT scans offer potential for sarcopenia assessment.
Purpose of the Study:
- To evaluate the association between cranial CT-based sarcopenia markers and neurological outcomes in CSDH surgery patients.
- To identify reliable imaging biomarkers for predicting recovery after CSDH surgery.
- To assess the utility of temporal muscle thickness as a predictor of neurological recovery.
Main Methods:
- Retrospective case-control study of 82 CSDH surgery patients.
- Preoperative CT scans analyzed for temporal muscle thickness, area, and occipital fat pad thickness.
- Neurological outcome assessed at 3 months using the Glasgow Outcome Scale.
Main Results:
- Greater temporal muscle thickness, area, and occipital fat pad thickness correlated with favorable neurological outcomes.
- Temporal muscle thickness was the sole independent predictor of good neurological recovery (OR 3.20, p=0.007) after adjustments.
- Temporal muscle thickness (cut-off ≥3.37 mm) demonstrated strong discriminatory power (AUC 0.812) for predicting favorable outcomes.
Conclusions:
- Temporal muscle thickness is a reliable, non-invasive imaging biomarker for predicting good neurological recovery after CSDH surgery.
- This CT-based marker can aid in risk stratification, especially for elderly or frail patients.
- Further research can integrate sarcopenia assessment into routine CSDH patient evaluation.

